Healthcare of Ontario Pension Plan Trust Fund Makes New $1.47 Million Investment in Bath & Body Works, Inc. (NYSE:BBWI)

Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 46,104 shares of the company’s stock, valued at approximately $1,472,000.

A number of other institutional investors have also recently bought and sold shares of the business. Anomaly Capital Management LP bought a new position in shares of Bath & Body Works during the 2nd quarter worth approximately $113,995,000. FMR LLC lifted its holdings in Bath & Body Works by 17,496.5% during the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after purchasing an additional 2,501,828 shares during the last quarter. KBC Group NV boosted its position in Bath & Body Works by 9,023.5% during the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after purchasing an additional 1,683,160 shares during the period. Lone Pine Capital LLC increased its holdings in shares of Bath & Body Works by 15.8% in the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after purchasing an additional 1,547,399 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its position in shares of Bath & Body Works by 723.4% in the third quarter. Assenagon Asset Management S.A. now owns 1,167,554 shares of the company’s stock valued at $37,268,000 after purchasing an additional 1,025,757 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Insider Activity

In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the company’s stock in a transaction dated Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.27% of the company’s stock.

Bath & Body Works Price Performance

NYSE:BBWI opened at $36.24 on Monday. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99. The firm’s 50 day simple moving average is $31.19 and its 200 day simple moving average is $35.48. The company has a market cap of $7.85 billion, a PE ratio of 8.84, a P/E/G ratio of 1.36 and a beta of 1.79.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.21%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio is currently 19.51%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on BBWI shares. Morgan Stanley reduced their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. Deutsche Bank Aktiengesellschaft increased their target price on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. BMO Capital Markets reaffirmed an “outperform” rating and issued a $50.00 price objective (down from $52.00) on shares of Bath & Body Works in a report on Thursday, August 29th. UBS Group dropped their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a report on Thursday, August 29th. Finally, Robert W. Baird decreased their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $41.88.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.